Injectable PEG Hydrogels with Tissue‐Like Viscoelasticity Formed through Reversible Alendronate‐Calcium Phosphate Crosslinking for Cell‐Material Interactions

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: de l'auteur⸱e
Licence: CC BY 4.0
ID Serval
serval:BIB_64C0C95DB644
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Injectable PEG Hydrogels with Tissue‐Like Viscoelasticity Formed through Reversible Alendronate‐Calcium Phosphate Crosslinking for Cell‐Material Interactions
Périodique
Advanced Healthcare Materials
Auteur⸱e⸱s
Yu Hongqiang, Yan Ziqian, Dreiss Cecile A., Gaitano Gustavo G., Jarvis James A., Gentleman Eileen, da Silva Ricardo M.P., Grigoriadis Agamemnon E
ISSN
2192-2640
2192-2659
Statut éditorial
Publié
Date de publication
29/05/2024
Langue
anglais
Résumé
<jats:title>Abstract</jats:title><jats:p>Synthetic hydrogels provide controllable 3D environments, which can be used to study fundamental biological phenomena. The growing body of evidence that cell behavior depends upon hydrogel stress relaxation creates a high demand for hydrogels with tissue‐like viscoelastic properties. Here, we have created a unique platform of synthetic PEG hydrogels in which star‐shaped PEG molecules were conjugated with alendronate and/or RGD peptides, attaining modifiable degradability as well as flexible cell adhesion. We identified novel reversible ionic interactions between alendronate and calcium phosphate nanoparticles, leading to versatile viscoelastic properties with varying initial elastic modulus and stress relaxation time. This new crosslinking mechanism provides shear‐thinning properties resulting in differential cellular responses between cancer cells and stem cells. The novel hydrogel system is an improved design to the other ionic crosslink platforms and opens new avenues for the development of pathologically relevant cancer models, as well as minimally‐invasive approaches for cell delivery for potential regenerative therapies.</jats:p><jats:p>This article is protected by copyright. All rights reserved</jats:p>
Création de la notice
04/06/2024 8:13
Dernière modification de la notice
05/06/2024 8:03
Données d'usage